{"id":56337,"date":"2023-04-28T14:05:24","date_gmt":"2023-04-28T12:05:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/"},"modified":"2023-04-28T14:05:24","modified_gmt":"2023-04-28T12:05:24","slug":"astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/","title":{"rendered":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop"},"content":{"rendered":"<div>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.astriatx.com&amp;esheet=53389034&amp;newsitemid=20230428005030&amp;lan=en-US&amp;anchor=Astria+Therapeutics%2C+Inc.&amp;index=1&amp;md5=86bfbeea6533cf29dcf6f120ef80bd15\" rel=\"nofollow noopener\" shape=\"rect\">Astria Therapeutics, Inc.<\/a> (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it will present information on STAR-0215 and its development in two presentations at the 13<sup>th<\/sup> C1-Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/4\/MicrosoftTeams-image.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nJou-Ku Chung, Vice President, Clinical Pharmacology and Translational Medicine at Astria Therapeutics, will present new human mechanistic modeling data in a poster titled \u201cMechanistic Modeling and Simulations Predict Long-Term HAE Attack Prevention with STAR-0215.\u201d The poster session will take place on Friday May 5, at 2:00pm CEST.<\/li>\n<li>\nDr. Marcus Maurer, M.D., Professor of Dermatology and Allergy at Charit\u00e9 Universit\u00e4tsmedizin in Berlin and Principal Investigator for the ALPHA-STAR trial, will present \u201cDesign of ALPHA-STAR, a Phase 1b\/2 Proof-of-Concept Trial of STAR-0215 as a Long-Acting Preventative Therapy in Patients with Hereditary Angioedema (HAE) Types I or II\u201d in an oral presentation on Saturday May 6, at 9:15am CEST.<\/li>\n<\/ul>\n<p>\n<b>About Astria Therapeutics:<\/b><\/p>\n<p>\nAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Learn more about our company on our website, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.astriatx.com&amp;esheet=53389034&amp;newsitemid=20230428005030&amp;lan=en-US&amp;anchor=www.astriatx.com&amp;index=2&amp;md5=0c85a30f8f949a20c46ac3869ea25ff9\" rel=\"nofollow noopener\" shape=\"rect\">www.astriatx.com<\/a>, or follow us on Twitter and Instagram @AstriaTx and on Facebook and LinkedIn.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<span class=\"bwuline\">Astria:<\/span><\/p>\n<p>\n<b>Investor relations:<\/b><br \/>Andrea Matthews<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#116;&#111;:in&#x76;&#x65;&#x73;&#x74;&#111;&#114;s&#64;a&#x73;&#x74;&#x72;&#x69;&#97;&#116;&#120;&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">in&#118;&#101;&#x73;&#x74;&#x6f;&#x72;s&#64;&#97;&#115;&#x74;&#x72;&#x69;&#x61;tx&#46;&#99;&#111;&#x6d;<\/a><\/p>\n<p>\n<b>Media:<\/b><br \/>Elizabeth Higgins<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;m&#101;&#x64;&#x69;a&#64;&#x61;s&#116;&#x72;&#x69;a&#116;&#x78;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#101;&#x64;&#105;a&#x40;&#97;s&#x74;&#114;&#x69;&#x61;t&#x78;&#46;c&#x6f;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56337","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON&#8211;(BUSINESS WIRE)&#8211;Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-28T12:05:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop\",\"datePublished\":\"2023-04-28T12:05:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/\"},\"wordCount\":269,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005030\\\/en\\\/1776968\\\/21\\\/MicrosoftTeams-image.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/\",\"name\":\"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005030\\\/en\\\/1776968\\\/21\\\/MicrosoftTeams-image.jpg\",\"datePublished\":\"2023-04-28T12:05:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005030\\\/en\\\/1776968\\\/21\\\/MicrosoftTeams-image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005030\\\/en\\\/1776968\\\/21\\\/MicrosoftTeams-image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/","og_locale":"en_US","og_type":"article","og_title":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend","og_description":"BOSTON&#8211;(BUSINESS WIRE)&#8211;Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company developing STAR-0215 for the treatment of hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-28T12:05:24+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop","datePublished":"2023-04-28T12:05:24+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/"},"wordCount":269,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/","url":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/","name":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg","datePublished":"2023-04-28T12:05:24+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230428005030\/en\/1776968\/21\/MicrosoftTeams-image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/astria-therapeutics-to-present-star-0215-at-the-13th-c1-inhibitor-deficiency-and-angioedema-workshop\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56337"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56337\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}